Drugs / CD19CD22 CAR-T
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT06078306 | Apr → Sep 2024 | B-cell acute lymphoblastic leukemia | The First Affiliated Hospital of Soochow University | Unknown | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | CD19CD22 CAR-T | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06078306 ↗ |
| Modality | Cell therapy | “CD19CD22 CAR-T cells” NCT06078306 ↗ |
| Route | Intravenous | “intravenous infusion” NCT06078306 ↗ |